Quarterly report [Sections 13 or 15(d)]

Unaudited Condensed Consolidated Statements of Operations

v3.26.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 4,352,668 $ 3,020,563 $ 8,842,633 $ 12,669,495
General and administrative 3,361,013 5,010,528 11,514,031 15,402,074
Total operating expenses 7,713,681 8,031,091 20,356,664 28,071,569
Gain on sale of ENTADFI® assets 0 484,615 0 2,154,134
Operating loss from continuing operations (7,713,681) (7,546,476) (20,356,664) (25,917,435)
Non-operating income (expenses):        
Gain on extinguishment of debt 0 0 0 8,624,778
Change in fair value of equity securities 546,129 0 4,357,467 (349,078)
Other income, net 179,202 223,375 585,718 656,338
Total non-operating income 725,331 223,375 4,943,185 8,932,038
Net loss from continuing operations (6,988,350) (7,323,101) (15,413,479) (16,985,397)
Net (loss) income from discontinued operations, net of taxes 0 (9,719) 351,418 (7,194,389)
Net loss $ (6,988,350) $ (7,332,820) $ (15,062,061) $ (24,179,786)
Net loss from continuing operations per basic and diluted common shares and pre-funded warrants outstanding (in dollars per share) $ (0.3) $ (0.5) $ (0.7) $ (1.16)
Net income (loss) from discontinued operations per basic and diluted common shares and pre-funded warrants outstanding (in dollars per share) 0 (0) 0.02 (0.49)
Net loss per basic and diluted common shares and pre-funded warrants outstanding (in dollars per share) $ (0.3) $ (0.5) $ (0.68) $ (1.65)
Basic and diluted weighted average common shares and pre-funded warrants outstanding (in shares) 23,050,320 14,657,777 22,127,243 14,644,927